Acetate group (n = 34) | Bicarbonate group (n = 35) | ||
---|---|---|---|
Age (years) | 58 (38–70) | 60 (40–74) | |
Females/Males | 11/23 | 10/25 | |
BMI (kg/m2) c | 25.1 (23.4–27.0) | 25.1 (22.6–28.6) | |
MELD | 13 (10–18) | 14 (9–18) | |
Abdominal surgery history a | 9 (26) | 9 (26) | |
Preoperative diagnosisa | Hepatic cell carcinoma | 13 (38) | 13 (37) |
HBV Cirrhosis | 14 (41) | 15 (43) | |
Others | 7 (21) | 7 (20) | |
Anhepatic phase duration (min) b | 40.1 ± 3.8 | 36.3 ± 3.6 | |
Operating time (min) b | 380 ± 108 | 400 ± 98 | |
Transfusion volume (mL) | 1200 (800–1350) | 1150 (600–1300) | |
Blood loss (mL) | 2437 (620–3973) | 2245 (750–3245) | |
Donor features | Age (years) | 55 (44–66) | 55 (46–65) |
Females/Males | 14/20 | 15/20 | |
BMI (kg/m2) | 26.3 (23.7–30.5) | 27.0 (23.7–30.6) | |
Brain death a | 26 (76) | 27 (77) | |
Heart death a | 8 (24) | 8 (23) |